Capital Growth Management’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-8,350,000
Closed -$38.6M 49
2019
Q3
$38.6M Buy
8,350,000
+6,150,000
+280% +$29.5M 2.95% 12
2019
Q2
$10.3M Buy
+2,200,000
New +$9.86M 0.72% 33
2019
Q1
Sell
-10,200,000
Closed -$40M 51
2018
Q4
$40M Buy
+10,200,000
New +$43.5M 2.51% 11
2018
Q3
Sell
-6,150,000
Closed -$28.5M 55
2018
Q2
$28.5M Buy
+6,150,000
New +$36.1M 1.44% 30

Other funds holding ABEV

Capital Growth Management's ABEV Position: Q4 2019 in Review

Capital Growth Management sold out of Ambev (ABEV) in Q4 2019, closing a stake of 8,350,000 shares — an estimated $38.6M sold.

Capital Growth Management first reported a position in ABEV in Q2 2018 and held it in 4 quarters. The position peaked at $40M in Q4 2018. 304 funds tracked by Wall St. Rank hold ABEV as of Q4 2019.

  • Capital Growth Management reported no remaining Ambev position as of Q4 2019 after selling out during the quarter.
  • Capital Growth Management sold 8,350,000 Ambev shares in Q4 2019, an estimated $38.6M.
  • Capital Growth Management first reported a position in Ambev in Q2 2018 and held it in 4 quarters.
  • Capital Growth Management's Ambev position peaked at $40M in Q4 2018.
  • 304 funds tracked by Wall St. Rank held Ambev as of Q4 2019.

Based on Capital Growth Management's 13F filing for Q4 2019, filed 13 Feb 2020.